Clinical Trial Update: High-dose Sequential Chemoimmunotherapy for B-cell Lymphomas With Central Nervous System Involvement [Phase 2]

View source ↗

Summary

Phase 2 study evaluating high-dose sequential chemoimmunotherapy for B-cell lymphomas with central nervous system involvement has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Non-hodgkin Lymphoma
• Central Nervous System Lymphoma

Snippet

Sponsor: Andrés José Maria Ferreri | Conditions: B-cell Lymphomas | Phase 2 | Status: COMPLETED | Results posted: 2024-12-10